Table 2.

Inhibitor treatments used in this study

Target	Inhibitor	Diluent	Incubation period
Pan-PKC	Chelerytherine chloride	HBSS+	1 h
PKC-α	HBDDE	HBSS+	1 h
PKC-α	Go 6976	DMSO	1 h
PKC-δ	Rottlerin	DMSO	1 h
PKC-ζ	Myristoylated PKC-ζ pseudosubstrate	HBSS+	1 h
MEK	PD98059	DMSO	1 h
P38	SB203580	DMSO	1 h
Pan-PLA2	ONO-RS-082	DMSO	3 h
5-LOX	Caffeic acid	DMSO	24 h
12/15-LOX	Baicalein	DMSO	48 h
MRP2	Probenecid	PBS, pH 7	24 h